Published 4 years ago • loading... • Updated 4 years ago

WHO recommends Roche, Sanofi drugs for COVID-19 to cut death risk

Summary by Ground News

Arthritis drugs tocilizumab and sarilumab reduce the risk of death and the need for ventilators among hospitalized Covid-19 patients, according to an analysis of nearly 11,000 patients. World Health Organization (WHO) recommends the use of the medicines, known as IL-6 inhibitors, in addition to corticosteroids among patients with severe Covid.

18 Articles

All

Left

Center

Right

Hindustan Times

WHO recommends lifesaving tocilizumab, sarilumab for critically ill Covid-19 patients

The WHO urged drug manufacturers to reduce prices of the IL-6 blocking drugs – tocilizumab and sarilumab – and make supplies available to low- and middle-income countries.

4 years ago·New Delhi, India

Read Full Article

WION

Study shows arthritis drugs tocilizumab and sarilumab reduce Covid deaths

Treating critically ill COVID-19 patients with arthritis drugs tocilizumab and sarilumab significantly improves survival rates and reduces the amount of time patients need intensive care. The immunosuppressive drugs, Actemra, also known as tocilizumab, and Kevzara, also known as sarilumab, reduced death rates by 8.5 percentage points among patients hospitalised and severely ill with the pandemic disease.

4 years ago·Noida, India

Read Full Article

IOL

WHO recommends new drugs for Covid-19 treatment

The World Health Organisation has recommended interleukin-6 receptor blockers for people with severe Covid-19, urging the producers to join efforts to rapidly increase the access to the drugs.

4 years ago·South Africa

Read Full Article

NBC News

Two arthritis drugs, plus steroids, can cut Covid death risk, WHO says

For every 100 patients given Actemra from Roche and Kevzara from Sanofi with corticosteroids, four more will survive, according to WHO analysis.

4 years ago·United States

Read Full Article

Al Jazeera

WHO adds ‘lifesaving’ drugs for severely ill COVID-19 patients

Interleukin-6 receptor blockers join corticosteroids on list of effective treatments for severe coronavirus.

4 years ago·Qatar

Read Full Article

Wall Street Journal

WHO Urges Covid-19 Treatment With Roche and Sanofi Anti-Inflammatory Drugs

The WHO added two drugs to its list of recommended treatments for certain hospitalized patients. The drugs, Actemra and Kevzara, target the haywire immune response to infections.

4 years ago·New York, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year